Skip to main content
Alert
This site has not been optimised for Internet Explorer due to Microsoft no longer providing support for the browser. Please view this site using another browser such as Google Chrome or Microsoft Edge.
Back to previous page

Specify brand advice guidance – updated July 2023

24 Jul 2024

Refreshed guidelines for the application of specify brand advice (SBA) for medicines within electronic systems.

The National Medication Safety Advisory Group supported and accepted the recommendation to amend rule 7 of Specify Brand Advice (SBA), to remove dry powder inhalers from the SBA list, in July 2023.


Published: 24 Jul 2024 Modified: 24 Jul 2024